Trial Profile
Impact of high-dose quinapril versus low-dose quinapril plus amlodipine on autonomic regulation and on sympathetic activation in response to cold exposure in hypertensive patients with impaired glucose tolerance, diabetes or coronary artery disease
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Quinapril (Primary) ; Amlodipine
- Indications Hypertension
- Focus Pharmacodynamics
- 05 May 2008 Trial discontinued due to slow recruitment- 2 patioents in nearly 2 years, according to clinicaltrials.gov record.
- 05 May 2008 Status changed from recruiting to discontinued according to clinicaltrials.gov record.
- 05 Nov 2006 New trial record.